Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hisashi Wada

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Scientific Reports|April 12, 2020
Tumour grade significantly correlates with total dysfunction of tumour tissue-infiltrating lymphocytes in renal cell carcinomaAtsunari Kawashima, Takayuki Kanazawa, Yujiro Kidani, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 11, 2014
Vaccination with NY-ESO-1 overlapping peptides mixed with Picibanil OK-432 and montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigenHisashi Wada, Midori Isobe, Kazuhiro Kakimi, et al.
NAR Cancer|May 16, 2024
Neural-net-based cell deconvolution from DNA methylation reveals tumor microenvironment associated with cancer prognosisYoshiaki Yasumizu, Masaki Hagiwara, Yuto Umezu, et al.
Nature Medicine|April 26, 2016
Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancersTakuro Saito, Hiroyoshi Nishikawa, Hisashi Wada, et al.
Cancer Immunity|April 20, 2007
T cell immunomonitoring and tumor responses in patients immunized with a complex of cholesterol-bearing hydrophobized pullulan (CHP) and NY-ESO-1 proteinAkiko Uenaka, Hisashi Wada, Midori Isobe, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 28, 2012
Clinical trial of the intratumoral administration of labeled DC combined with systemic chemotherapy for esophageal cancerShinichi Fujiwara, Hisashi Wada, Hiroshi Miyata, et al.
International Journal of Cancer|March 18, 2011
Heteroclitic serological response in esophageal and prostate cancer patients after NY-ESO-1 protein vaccinationJunji Kawada, Hisashi Wada, Midori Isobe, et al.
International Immunology|January 18, 2020
Clinical importance of the expression of CD4+CD8+ T cells in renal cell carcinomaKentaro Nishida, Atsunari Kawashima, Takayuki Kanazawa, et al.
Cancer Research|March 18, 2004
NY-ESO-1 expression and immunogenicity in malignant and benign breast tumorsYurika Sugita, Hisashi Wada, Shoichiro Fujita, et al.
International Journal of Cancer|December 18, 2024
A novel mouse model of upper tract urothelial carcinoma highlights the impact of dietary intervention on gut microbiota and carcinogenesis prevention despite carcinogen exposureAkinaru Yamamoto, Atsunari Kawashima, Toshihiro Uemura, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Scientific Reports|April 12, 2020
Tumour grade significantly correlates with total dysfunction of tumour tissue-infiltrating lymphocytes in renal cell carcinomaAtsunari Kawashima, Takayuki Kanazawa, Yujiro Kidani, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 11, 2014
Vaccination with NY-ESO-1 overlapping peptides mixed with Picibanil OK-432 and montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigenHisashi Wada, Midori Isobe, Kazuhiro Kakimi, et al.
NAR Cancer|May 16, 2024
Neural-net-based cell deconvolution from DNA methylation reveals tumor microenvironment associated with cancer prognosisYoshiaki Yasumizu, Masaki Hagiwara, Yuto Umezu, et al.
Nature Medicine|April 26, 2016
Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancersTakuro Saito, Hiroyoshi Nishikawa, Hisashi Wada, et al.
Cancer Immunity|April 20, 2007
T cell immunomonitoring and tumor responses in patients immunized with a complex of cholesterol-bearing hydrophobized pullulan (CHP) and NY-ESO-1 proteinAkiko Uenaka, Hisashi Wada, Midori Isobe, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 28, 2012
Clinical trial of the intratumoral administration of labeled DC combined with systemic chemotherapy for esophageal cancerShinichi Fujiwara, Hisashi Wada, Hiroshi Miyata, et al.
International Journal of Cancer|March 18, 2011
Heteroclitic serological response in esophageal and prostate cancer patients after NY-ESO-1 protein vaccinationJunji Kawada, Hisashi Wada, Midori Isobe, et al.
International Immunology|January 18, 2020
Clinical importance of the expression of CD4+CD8+ T cells in renal cell carcinomaKentaro Nishida, Atsunari Kawashima, Takayuki Kanazawa, et al.
Cancer Research|March 18, 2004
NY-ESO-1 expression and immunogenicity in malignant and benign breast tumorsYurika Sugita, Hisashi Wada, Shoichiro Fujita, et al.
International Journal of Cancer|December 18, 2024
A novel mouse model of upper tract urothelial carcinoma highlights the impact of dietary intervention on gut microbiota and carcinogenesis prevention despite carcinogen exposureAkinaru Yamamoto, Atsunari Kawashima, Toshihiro Uemura, et al.
Pageof 10